Compare Medpace Holdings Inc (MEDP) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Southern Copper Corp — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while Southern Copper Corp trades at $209.75 (market cap $167.74B). The key difference: Southern Copper Corp is far larger — about 10× Medpace Holdings Inc's market cap, and Southern Copper Corp pays a 2.21% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Southern Copper Corp for 61 Days on average.
| MEDP | SCCO | |
|---|---|---|
Market Cap | $16.82B | $167.74B |
Volume | 223,093 | 853,110 |
Sector | Health | Basic Materials |
52-Week High | $630.19 | $219.70 |
52-Week Low | $393.42 | $120.02 |
Typical Hold Time | 14 Days | 61 Days |
Enterprise Value | $16.44B | $169.03B |
Dividend Yield | — | 2.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
Southern Copper (SCCO) trades at $209.21, up 4.31% with strong earnings momentum, beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains robust fundamentals with 35.87% net margins and 50.07% ROE. Recent news highlights the company's $10.2B Mexican project pipeline as a long-term growth driver while current sentiment remains mixed amid copper price volatility.
SCCO presents a valuation premium with P/E of 29.81 and P/S of 10.72, trading above analyst consensus target of $167.67. While operational excellence and project pipeline support upside potential, elevated valuation and bearish technicals suggest near-term caution. The stock faces headwinds from copper market volatility and competitive pressures in the materials sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
